vs
Side-by-side financial comparison of Edwards Lifesciences (EW) and ROGERS COMMUNICATIONS INC (RCI). Click either name above to swap in a different company.
Edwards Lifesciences is the larger business by last-quarter revenue ($1.6B vs $978.2M, roughly 1.7× ROGERS COMMUNICATIONS INC).
Edwards Lifesciences Corporation is an American medical technology company headquartered in Irvine, California, specializing in artificial heart valves and hemodynamic monitoring. It developed the Sapien transcatheter aortic heart valve made of cow tissue within a balloon-expandable, cobalt-chromium frame, deployed via catheter.
Rogers Communications Inc. is a Canadian communications and media company operating primarily in the fields of wireless communications, cable television, telephony and Internet, with significant additional telecommunications, mass media, and professional sports assets. Rogers has its headquarters in Toronto, Ontario.
EW vs RCI — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2023
| Metric | | |
|---|---|---|
| Revenue | $1.6B | $978.2M |
| Net Profit | $380.7M | — |
| Gross Margin | 78.0% | — |
| Operating Margin | 1.8% | — |
| Net Margin | 23.1% | — |
| Revenue YoY | 16.7% | — |
| Net Profit YoY | 6.8% | — |
| EPS (diluted) | $0.66 | $0.15 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $1.6B | — | ||
| Q4 25 | $1.6B | — | ||
| Q3 25 | $1.6B | — | ||
| Q2 25 | $1.5B | — | ||
| Q1 25 | $1.4B | — | ||
| Q4 24 | $1.4B | — | ||
| Q3 24 | $1.4B | — | ||
| Q2 24 | $1.4B | — |
| Q1 26 | $380.7M | — | ||
| Q4 25 | $91.2M | — | ||
| Q3 25 | $291.1M | — | ||
| Q2 25 | $333.2M | — | ||
| Q1 25 | $358.0M | — | ||
| Q4 24 | $385.6M | — | ||
| Q3 24 | $3.1B | — | ||
| Q2 24 | $366.3M | — |
| Q1 26 | 78.0% | — | ||
| Q4 25 | 78.1% | — | ||
| Q3 25 | 77.8% | — | ||
| Q2 25 | 77.5% | — | ||
| Q1 25 | 78.7% | — | ||
| Q4 24 | 78.9% | — | ||
| Q3 24 | 80.6% | — | ||
| Q2 24 | 79.9% | — |
| Q1 26 | 1.8% | — | ||
| Q4 25 | 9.6% | — | ||
| Q3 25 | 19.8% | — | ||
| Q2 25 | 26.8% | — | ||
| Q1 25 | 27.9% | — | ||
| Q4 24 | 22.6% | — | ||
| Q3 24 | 25.9% | — | ||
| Q2 24 | 26.8% | — |
| Q1 26 | 23.1% | — | ||
| Q4 25 | 5.8% | — | ||
| Q3 25 | 18.7% | — | ||
| Q2 25 | 21.7% | — | ||
| Q1 25 | 25.3% | — | ||
| Q4 24 | 27.8% | — | ||
| Q3 24 | 226.7% | — | ||
| Q2 24 | 26.7% | — |
| Q1 26 | $0.66 | — | ||
| Q4 25 | $0.16 | — | ||
| Q3 25 | $0.50 | — | ||
| Q2 25 | $0.56 | — | ||
| Q1 25 | $0.61 | — | ||
| Q4 24 | $0.65 | — | ||
| Q3 24 | $5.13 | — | ||
| Q2 24 | $0.61 | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
